-+ 0.00%
-+ 0.00%
-+ 0.00%

Mizuho Maintains Outperform on Surgery Partners, Lowers Price Target to $22

Benzinga·11/17/2025 17:40:48
Listen to the news
Mizuho analyst Ann Hynes maintains Surgery Partners (NASDAQ:SGRY) with a Outperform and lowers the price target from $28 to $22.